The Translational Research and Development Laboratory (TRDL) focuses on translating important scientific innovations into products and services to help patients suffering from blood diseases and/or otherwise in need of safe, effective blood transfusions.

Dr. Bruce Sachais Exec VP/Chief Medical Officer at New York Blood Center Enterprises, smiling in laboratory
Dr. Bruce Sachais, Senior Vice President, Enterprise Chief Medical Officer and Head of Translational Research and Development Laboratory

This newly created laboratory is led by Dr. Bruce Sachais, MD, PhD. Dr. Sachais also serves as Chief Medical Officer for New York Blood Center Enterprises (NYBCe) and Medical Director of the Blood Bank of Delmarva. With laboratories based in New York City and Delaware, we are working with other research, development, and clinical laboratories within NYBCe as well as partner start-up and biotechnology companies to create the future of Transfusion Medicine and develop novel therapies for hematology patients.

Current internal projects focus on the development of a novel treatment for Heparin Induced Thrombocytopenia, as well as methods to treat and improve blood and blood products for transfusion.

Partnership Opportunities

We offer development, contract for service, consulting, and wet diligence services.

Current TRDL services include:

  • Blood component preparation
  • Analysis of whole blood and blood components (RBCs, platelets, plasma, and white cells)
  • Immunohematology
  • Plasma and whole blood coagulation
  • Bacterial sterility testing
  • Provide research supply of blood products
  • Hematology
  • Consulting services
  • Other biological analyses

Our Team and Clinical Laboratory Collaborators

NYBCe laboratory team (New York City and Delaware)

o Connor McCloskey, BS, Laboratory Supervisor
o Jason Sperry, BS, Research Scientist
o Ping Han, MS, Research Scientist
o Linette Johnson, BS, Research Scientist, Quality Lead
o Sarah McMahon, BA, Program Specialist

Blood Bank of Delmarva clinical laboratories and quality oversight collaboration team (Delaware)
o Kristin Frederick, MLS, SBB, Director of Laboratories, BBD
o Margaret Hannan, MS, Director, Quality and Regulatory Affairs, BBD
o Chloe Thompson, MLS, SBB, Reference Laboratory Supervisor, BBD
o Stacy McCardell, Manager of Component Laboratory, BBD
o Alyssa Lepore, MLS, Quality Specialist II, BBD
o Merisa Hernandez, Lead Tech, Component Lab, BBD

Contact Us

If you are interested in partnering with us, please contact [email protected].

Visit NYBC Ventures to learn more about funding opportunities.